Recent Finacing
Recent Raise
ArmaGen Technologies develops a protein engineering platform to modify recombinant therapeutics for blood–brain barrier penetration and develops biopharmaceutical programs targeting orphan CNS diseases, including MPS I and II.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors